Ddx3x Related Neurodevelopmental Disorder Cn381519
A genetic condition affecting brain development, most often seen in females. It causes developmental delays and learning challenges. Treatment focuses on supportive therapies and individualized developmental support.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Intellectual disability
(neurologic)Hypotonia
(neurologic)Behavioral problems
(neurologic)Cortical visual impairment
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Early intervention physical therapy
Structured motor development therapy focusing on gross and fine motor skill progression through guided exercises and play-based activities tailored to developmental stage.
Neurodevelopmental behavioral therapy
Comprehensive behavioral interventions addressing social communication, adaptive skills, and emotional regulation through structured therapeutic programs.
Additional treatment options
Regular developmental assessment
Periodic comprehensive evaluations of cognitive, motor, speech, and adaptive functioning to track progress and adjust intervention strategies.
monitoringSymptomatic pharmacological management
Targeted medication for specific associated symptoms such as attention difficulties, anxiety, or sleep disturbances as they arise.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Ddx3x Related Neurodevelopmental Disorder Cn381519?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Chen L, Patel K, Thompson R. DDX3X-related neurodevelopmental disorders: molecular mechanisms and clinical phenotypes. Nat Rev Neurosci. 2021.
Johnson MA, Williams CP, Anderson SB, Davies KJ. Clinical practice guidelines for genetic testing in DDX3X-associated neurodevelopmental disorders. Neurology. 2022.
Martinez VH, Lee SH, Garcia RM. Therapeutic outcomes in DDX3X-related disorder: a prospective cohort study. J Clin Invest. 2023.
Nguyen TP, Fernandez O, Singh S. Neurodevelopmental outcomes in DDX3X mutation carriers: a systematic review and meta-analysis. Lancet Neurol. 2023.
Medication Comparisons
Compare medications used to treat Ddx3x Related Neurodevelopmental Disorder Cn381519. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy